Retail & Wholesale » Retail | Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
3,046.30
4,468.20
6,368.00
2,578.30
2,856.00
6,797
Total Accounts Receivable
4,793.80
4,427.10
15,385.20
18,991.90
12,714.40
9,990
Inventories
10,753.60
9,558.60
22,684.70
26,266.50
22,228.60
17,301
Other Current Assets
574.90
654.10
601.70
1,149.60
1,706.00
589
Total Current Assets
19,168.70
19,108.10
45,039.60
48,986.20
39,504.90
34,677
Net Property, Plant & Equipment
5,180.60
4,654.50
11,816.60
15,840.70
9,913.40
7,174
Intangible Assets
587.00
655.50
81,771.90
77,475.40
55,361.00
3,778
Other Assets
3,941.40
3,532.80
2,399.10
1,799.20
925.30
793
Total Assets
28,877.60
27,950.90
141,027.30
144,101.60
105,704.60
46,422
ST Debt & Current Portion LT Debt
1,056.40
1,113.40
35.10
10,693.10
365.50
Accounts Payable
3,415.50
4,127.40
10,793.30
11,112.40
9,475.80
Other Current Liabilities
5,179.70
3,241.70
10,646.20
9,315.80
15,976.50
Total Current Liabilities
9,651.60
8,482.50
21,474.60
31,121.30
25,817.80
Long-Term Debt
23,068.30
27,243.40
107,975.70
112,404.80
127,003.50
Other Liabilities
-
-
2,700.50
7,648.80
11,582.30
Total Liabilities
32,719.80
35,725.80
132,150.80
151,174.90
164,403.60
Common Equity (Total)
3,842.20
7,774.90
8,876.50
7,073.30
58,699.00
Total Shareholders' Equity
3,842.20
7,774.90
8,876.50
7,073.30
58,699.00
Total Equity
3,842.20
7,774.90
8,876.50
7,073.30
58,699.00
Liabilities & Shareholders' Equity
28,877.60
27,950.90
141,027.30
144,101.60
105,704.60

About Xtant Medical Holdings

View Profile
Address
664 Cruiser Lane
Belgrade Montana 59714
United States
Employees -
Website http://www.xtantmedical.com
Updated 07/08/2019
Xtant Medical Holdings, Inc. operates as a holding company, which supplies orthopedic and spine surgery products. The firm operates through its subsidiaries, Bacterin International, Inc. and X-spine Systems, Inc. Bacterin International develops, manufactures, and markets biologics products to domestic and international markets. Its products are bone graft, which are used in promotion of skull healing following neurosurgery and subchondral bone repair in knee and other joint surgeries; and custom surgical products used for allografts.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.